For the Inventor, By the Inventor

Enter assignee name

Edmonton, Canada

Biomira, Inc.

USPTO Granted Patents = 16

% Expired Patents = 12.5

CIPO Patents = 1

Forward Citations = 160

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

B Michael Longenecker (8 out of 14 patents)

Carina Henningsson (4 out of 4 patents)

R Rao Koganty (3 out of 7 patents)

4. Babita Agrawal (2 out of 10 patents)

5. John Samuel (2 out of 4 patents)

6. Sham Gandhi (2 out of 2 patents)

7. Rao R Koganty (2 out of 3 patents)

8. Damayanthi Yalamati (1 out of 3 patents)

9. Selvaraj A Naicker (1 out of 28 patents)

10. Mark J Krantz (1 out of 3 patents)

11. Zi-Hua Jiang (1 out of 3 patents)

12. Mimi Bach (1 out of 1 patent)

13. Michael Longenecker (1 out of 1 patent)

14. Mark A Reddish (1 out of 1 patent)

15. Ting Chi Wong (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 7491707 - Synthetic lipid-a-analogs and uses thereof (2009-02-17),

2. 6600012 - Lipid-modified muc-1 derivatives (2003-07-29),

3. 6582697 - Enhancement of the cellular immune response (2003-06-24),

4. 6326009 - Enhancement of the cellular immune response (2001-12-04),

5. 6114129 - Methods of detecting T-cell activation and treating disorders associated (2000-09-05),

6. 6013779 - Process for preparation of glycosides of tumor-associated carbohydrate (2000-01-11),

7. 5837830 - Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides (1998-11-17),

8. 5798090 - Enhancement of the cellular immune response (1998-08-25),

9. 5527891 - Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides (1996-06-18),

10. 5455332 - Carcinoma-marking monoclonal antibodies elicited with synthetic (1995-10-03),

11. 5242799 - Lectin-antibody immunoassays for TF epitope-bearing antigens (1993-09-07),

12. 5110911 - Human tumor-associated Thomsen-Friedenreich antigen (1992-05-05),

13. 5075218 - Screening for antibodies which bind carbohydrate epitopes of (1991-12-24),

14. 5055562 - Fluorocarbon chain-containing antigenic conjugates (1991-10-08),

15. 4971795 - Enhancement of the cellular immune response using carbohydrate primed (1990-11-20),

Company Overview

Biomira, Inc. is a biotechnology company based in Edmonton, Canada, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing treatments primarily in the fields of oncology and immunotherapy, leveraging cutting-edge research to address unmet medical needs. With a commitment to improving patient outcomes, Biomira engages in the discovery and commercialization of novel drug candidates, aiming to enhance the quality of life for individuals affected by cancer and other serious diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#18 in Edmonton

#930 in Canada

#37,831 in the World

Edmonton, Canada

Biomira, Inc.

Forward Citations = 160

24 inventors:

B Michael Longenecker (8 out of 14 patents)

Carina Henningsson (4 out of 4 patents)

R Rao Koganty (3 out of 7 patents)

4. Babita Agrawal (2 out of 10 patents)

5. John Samuel (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomira, Inc.. Retrieved from https://idiyas.com/company/biomira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…